tiprankstipranks
SUPN Earnings this Week: How Will it Perform?
PremiumPre-EarningsSUPN Earnings this Week: How Will it Perform?
19d ago
Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities
Premium
Ratings
Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities
2M ago
Serina Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Serina Therapeutics initiated with a Buy at JonesResearch
2M ago
Supernus sees FY25 revenue $600M-$630M, consensus $622.27M
PremiumThe FlySupernus sees FY25 revenue $600M-$630M, consensus $622.27M
3M ago
Supernus Pharmaceuticals Updates Executive Compensation Packages
Premium
Company Announcements
Supernus Pharmaceuticals Updates Executive Compensation Packages
3M ago
SUPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SUPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Supernus announces FDA approval of ONAPGO
PremiumThe FlySupernus announces FDA approval of ONAPGO
4M ago
Supernus announces U.S. FDA approved an update for label for Qelbree
Premium
The Fly
Supernus announces U.S. FDA approved an update for label for Qelbree
4M ago
Supernus initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Supernus initiated with an Overweight at Cantor Fitzgerald
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100